L-Histidine API Market

L-Histidine API Market Size, Share & Industry Analysis, By Type (L-Histidine Hydrochloride Monohydrate, L-Histidine Base, USP/EP/BP Grade, Food Grade, Pharmaceutical Grade, and Reagent Grade), By Application (Pharmaceuticals, Dietary Supplements & Nutraceuticals, and Research & Development)   By End-User (Pharmaceutical Companies, Contract Manufacturing Organizations (CMOs), Biotechnology Firms, Academic and Research Institutes, and Nutraceutical Manufacturers) By Route of Administration (Intravenous (IV), Oral, and Parenteral) By Distribution Channel (Direct Sales, Distributors/Wholesalers, and Online Pharmacies) and Forecast, 2025-2035

The L-Histidine API market is projected to grow at a CAGR of 4.3% from 2025 to 2035, fueled by increasing demand in the pharmaceutical and nutraceutical sectors. L-Histidine is an essential amino acid used as an Active Pharmaceutical Ingredient (API) in intravenous (IV) formulations, metabolic disorder treatments, and nutritional therapies.

Among the various product types, pharmaceutical-grade L-Histidine dominates the market and is expected to maintain its leading position throughout the forecast period. This segment benefits from its use in parenteral nutrition, particularly for patients with kidney disorders or those undergoing surgery. Meanwhile, nutraceutical-grade L-Histidine is emerging as a fast-growing segment, driven by the increasing use of amino acid supplements in sports nutrition and elderly health support.

Geographically, Asia-Pacific leads the global market, with China, India, and Japan serving as major production and consumption hubs. China, in particular, stands out due to its robust pharmaceutical manufacturing ecosystem and the presence of multiple API producers. Additionally, India’s expanding contract manufacturing and export capabilities further strengthen the region’s dominance in the market.

The L-Histidine API market features a competitive landscape with several global and regional players. Key companies include Ajinomoto Co., Inc., Kyowa Hakko Bio Co., Ltd., Evonik Industries AG, CJ CheilJedang Corp., and Shijiazhuang Jirong Pharmaceutical Co., Ltd. These firms are focusing on innovation, product purity, and regulatory compliance to enhance their global footprint and meet growing demand from pharmaceutical and biopharma clients across regulated markets.

Seeking Comprehensive Intelligence on Different markets? Get in Touch with our Experts

Report Scope & Segmentation

  1. Introduction
  • Overview of L-Histidine API
  • Key Applications & Industry Use Cases
  • Market Scope & Study Objectives
  1. Market Overview
  • Global Market Size & Growth Trends (Historical & Forecast)
  • Market Value & Revenue Analysis
  • Demand-Supply Dynamics
  1. Segmental Outlook
  • By Type
    • L-Histidine Hydrochloride Monohydrate
    • L-Histidine Base
    • USP/EP/BP Grade
    • Food Grade
    • Pharmaceutical Grade
    • Reagent Grade
  • By Application
  • Pharmaceuticals
  • Dietary Supplements & Nutraceuticals
  • Research & Development)
  • Key End-Use Industries
    • Pharmaceutical Companies
    • Contract Manufacturing Organizations (CMOs)
    • Biotechnology Firms
    • Academic and Research Institutes
    • Nutraceutical Manufacturers
  • By Route of Administration
  • Intravenous (IV)
  • Oral
  • Parenteral
  • By Distribution Channel
  • Direct Sales
  • Distributors/Wholesalers
  • Online Pharmacies
  1. Price Analysis
  • Current Price Trends (Per kg & Per Ton)
  • Price Fluctuation Factors (Raw Material Costs, Production, Trade Tariffs)
  • Regional Price Comparison (North America, Europe, Asia-Pacific, and Other)
  1. Production & Supply Volume
  • Global Production Capacity & Key Manufacturers
  • Production Process & Technological Developments
  • Raw Material Analysis
  1. Trade Analysis (Import & Export)
  • Major Exporting & Importing Countries
  • Trade Volume & Value Statistics
  • Impact of Trade Regulations & Policies
  1. Regional Analysis
  • North America (US and Canada)
  • Europe (UK, Germany, France, Italy, Spain, and Rest of Europe)
  • Asia-Pacific (China, Japan, South Korea, Taiwan, India, and Rest of Asia-Pacific)
  • Rest of the World (Latin America, Middle East, and Africa)
  1. Competitive Landscape
  • Top Global Manufacturers & Market Share
  • Company Profiles & Key Developments
  • Mergers, Acquisitions & Investments
  1. Regulatory & Compliance Factors
  • FDA, REACH, and Other Regulatory Frameworks
  • Environmental & Safety Considerations
  • Emerging Policies Impacting Market Growth
  1. Conclusion & Strategic Recommendations
  • Key Takeaways for Stakeholders
  • Market Entry Strategies
What is L-Histidine API?
L-Histidine API is the active pharmaceutical ingredient form of the essential amino acid L-Histidine, used in medications, nutritional infusions, and research applications.
What is the projected CAGR of the L-Histidine API market from 2024 to 2030?
The global L-Histidine API market is expected to grow at a CAGR of 4.3% during the forecast period 2025–2035.
Which segment leads the L-Histidine API market?
The pharmaceutical-grade segment holds the largest share due to its application in IV nutrition and metabolic treatments.
Which region dominates the L-Histidine API market?
Asia-Pacific, particularly China and India, leads the market due to strong manufacturing capabilities and growing pharmaceutical demand.
Who are the key players in the global L-Histidine API market?
Major players include Ajinomoto Co., Inc., Kyowa Hakko Bio, Evonik Industries, CJ CheilJedang, and Shijiazhuang Jirong Pharmaceutical.
What are the main applications of L-Histidine API?
It is primarily used in parenteral nutrition, metabolic disorder treatment, dietary supplements, and cell culture media.
$1800/- Single User License
$3600/- Multi User License

How can we help you?

Reach out to discuss how our team can help your business achieve real results.